News
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
NanoViricides Comments on the Need for Broad-Spectrum Antivirals in Light of the Current Influenza Wave - NV-387 is Effective Against H3N2
NanoViricides, Inc. declares need for broad-spectrum antivirals amid severe influenza epidemic, highlighting potential of NV-387 against multiple viruses -
-
-
COMMUNIQUÉ DE PRESSE
NanoViricides Has Signed a Master Services Agreement with OnlyOrphansCote Regarding Orphan Drug Strategy of NV-387 for Treatment of MPox, Smallpox, and Measles
NanoViricides, Inc. signs MSA with regulatory consultant firm for orphan drug strategy development for NV-387, a broad-spectrum antiviral with potential against Smallpox, Measles, and more -
